JP2016502406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016502406A5 JP2016502406A5 JP2015543486A JP2015543486A JP2016502406A5 JP 2016502406 A5 JP2016502406 A5 JP 2016502406A5 JP 2015543486 A JP2015543486 A JP 2015543486A JP 2015543486 A JP2015543486 A JP 2015543486A JP 2016502406 A5 JP2016502406 A5 JP 2016502406A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- seq
- neurodegenerative disease
- neurodegenerative
- prediction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004770 neurodegeneration Effects 0.000 claims 35
- 208000015122 neurodegenerative disease Diseases 0.000 claims 35
- 238000003745 diagnosis Methods 0.000 claims 19
- 238000000338 in vitro Methods 0.000 claims 15
- 238000000034 method Methods 0.000 claims 13
- 108020005196 Mitochondrial DNA Proteins 0.000 claims 9
- 208000024827 Alzheimer disease Diseases 0.000 claims 8
- 239000012472 biological sample Substances 0.000 claims 5
- 208000018737 Parkinson disease Diseases 0.000 claims 4
- 238000011304 droplet digital PCR Methods 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 2
- 210000002381 plasma Anatomy 0.000 claims 2
- 238000003753 real-time PCR Methods 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 238000002105 Southern blotting Methods 0.000 claims 1
- 239000000090 biomarker Substances 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- 210000001138 tear Anatomy 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201231807A ES2482866B1 (es) | 2012-11-22 | 2012-11-22 | Método de diagnóstico y/o pronóstico de enfermedades neurodegenerativas. |
| ESP201231807 | 2012-11-22 | ||
| PCT/ES2013/070713 WO2014080054A1 (es) | 2012-11-22 | 2013-10-17 | Método de diagnóstico y/o pronóstico de enfermedades neurodegenerativas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016502406A JP2016502406A (ja) | 2016-01-28 |
| JP2016502406A5 true JP2016502406A5 (cg-RX-API-DMAC7.html) | 2016-12-01 |
Family
ID=50775580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015543486A Pending JP2016502406A (ja) | 2012-11-22 | 2013-10-17 | 神経変性疾患の診断及び／又は予知の方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150361495A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2924124A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2016502406A (cg-RX-API-DMAC7.html) |
| ES (1) | ES2482866B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014080054A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3181701A1 (en) * | 2015-12-17 | 2017-06-21 | Consejo Superior De Investigaciones Cientificas | Method for the sub-classification of patients suffering from parkinson disease |
| EP3438260B1 (en) * | 2016-03-28 | 2023-06-07 | Osaka University | Eye disease biomarker |
| EP3438281A4 (en) * | 2016-03-28 | 2019-09-11 | Osaka University | STRESSBIOMARKER |
| FR3144164A1 (fr) | 2022-12-23 | 2024-06-28 | Neolys Diagnostics | Détermination du statut d’un individu vis-à-vis de la maladie d’Alzheimer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5494794A (en) * | 1992-10-20 | 1996-02-27 | Emory University | Detection of mitochondrial DNA mutations associated with Alzheimer's disease and Parkinson's disease |
| JPH1099085A (ja) * | 1996-05-16 | 1998-04-21 | Affymetrix Inc | ヒトミトコンドリアｄｎａの多形性 |
| US6218117B1 (en) * | 1998-06-15 | 2001-04-17 | Mitokor | Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios |
| US6441149B1 (en) * | 1998-06-15 | 2002-08-27 | Mitokor | Diagnostic method based on quantification of extramitochondrial DNA |
| EP1208225A2 (en) * | 1999-04-20 | 2002-05-29 | Mitokor | Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease |
| EP1395681B1 (en) * | 2001-05-29 | 2006-07-26 | The University of British Columbia | Pharmacological applications of mitochondrial dna assays |
| US20040009518A1 (en) * | 2002-05-14 | 2004-01-15 | The Chinese University Of Hong Kong | Methods for evaluating a disease condition by nucleic acid detection and fractionation |
| EP1769089A4 (en) * | 2004-03-29 | 2009-04-15 | Univ California | METHOD AND COMPOSITIONS FOR THE PRE- OR POST-SYMPTOMATIC DIAGNOSIS OF ALZHEIMER AND OTHER NEURODEGENERATIVE DISEASES |
| DK1877559T3 (da) * | 2005-04-18 | 2011-02-07 | Mitomics Inc | Mitochondrial mutationer og omarrangeringer som et diagnostisk værktøj for detektion af soleksponering, prostatacancer og andre cancertyper |
| US20100168051A1 (en) * | 2007-03-23 | 2010-07-01 | Afshan Malik | Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress |
| US9050275B2 (en) * | 2009-08-03 | 2015-06-09 | Theta Biomedical Consulting & Development Co., Inc. | Methods of screening for and treating autism spectrum disorders and compositions for same |
| EP2504448B1 (en) * | 2009-11-25 | 2016-10-19 | Bio-Rad Laboratories, Inc. | Methods and compositions for detecting genetic material |
| JP5831919B2 (ja) * | 2011-02-21 | 2015-12-09 | 国立大学法人北海道大学 | 神経変性疾患の検査方法 |
-
2012
- 2012-11-22 ES ES201231807A patent/ES2482866B1/es not_active Expired - Fee Related
-
2013
- 2013-10-17 WO PCT/ES2013/070713 patent/WO2014080054A1/es not_active Ceased
- 2013-10-17 US US14/443,607 patent/US20150361495A1/en not_active Abandoned
- 2013-10-17 JP JP2015543486A patent/JP2016502406A/ja active Pending
- 2013-10-17 EP EP13856389.5A patent/EP2924124A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Olsson et al. | Biomarker-based dissection of neurodegenerative diseases | |
| Díaz-Gimeno et al. | A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature | |
| Chan et al. | Applications of blood-based protein biomarker strategies in the study of psychiatric disorders | |
| JP2013503617A5 (cg-RX-API-DMAC7.html) | ||
| JP2016105097A5 (cg-RX-API-DMAC7.html) | ||
| GB2488700B (en) | Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual | |
| JP6681976B2 (ja) | 初期アルツハイマー病又は軽度認知障害の診断方法 | |
| Sheinerman et al. | Early detection of neurodegenerative diseases: circulating brain-enriched microRNA | |
| WO2011142827A3 (en) | Diagnostic markers for neuropsychiatric disease | |
| WO2015071876A3 (en) | Use of microrna markers for diagnosis of thyroid tumors and a diagnostic panel containing such markers. | |
| ES2993025T3 (en) | Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases | |
| EP3236262A3 (en) | Surrogate functional diagnostics test for cancer | |
| WO2017025617A8 (en) | Method for the quantification of faecalibacterium prausnitzii phylogroup i and/or phylogroup ii members and the use thereof as biomarkers | |
| JP2016502406A5 (cg-RX-API-DMAC7.html) | ||
| WO2017027685A3 (en) | Antibody-based molecules specific for the truncated asp421 epitope of tau and their uses in the diagnosis and treatment of tauopathy | |
| Jovčevska et al. | Neuroepigenetics of psychiatric disorders: Focus on lncRNA | |
| WO2010047938A3 (en) | Mmp activation peptide detection in biological samples | |
| JP2013504766A5 (cg-RX-API-DMAC7.html) | ||
| WO2010045611A3 (en) | Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (sle) and other autoimmune diseases | |
| BR112014031957A2 (pt) | bag3 como soro bioquímico e marcador de tecido | |
| WO2005098433A3 (en) | Diagnostic assays for alzheimer’s disease | |
| WO2014177867A3 (en) | Differentially expressed biomarkers for alzheimer's disease | |
| WO2013064702A3 (en) | Probes for diagnosis and monitoring of neurodegenerative disease | |
| WO2014117680A3 (zh) | 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆 | |
| CN113025705B (zh) | miRNA-214作为帕金森病前驱期生物标志物的应用 |